Camrelizumab Versus Placebo in Combination with Gemcitabine and Cisplatin As First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (Captain-1St): a Multicentre, Randomised, Double-Blind, Phase 3 TrialYunpeng Yang,Song Qu,Jingao Li,Chaosu Hu,Mingjun Xu,Weidong Li,Ting Zhou,Liangfang Shen,Hui Wu,Jinyi Lang,Guangyuan Hu,Zhanxiong Luo,Zhichao Fu,Shenhong Qu,Weineng Feng,Xiaozhong Chen,Shaojun Lin,Weimin Zhang,Xiaojiang Li, Yan Sun,Zhixiong Lin,Qin Lin,Feng Lei,Jianting Long,Jinsheng Hong,Xiaoming Huang, Lingzhi Zeng,Peiguo Wang,Xiaohui He,Ben Zhang, Qing Yang,Xiaojing Zhang,Jianjun Zou,Wenfeng Fang,Li ZhangLANCET ONCOLOGY（2021）引用 254|浏览54关键词Combination TherapiesAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
